Reuters logo
BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise unit receives GMP certificate
June 30, 2017 / 7:17 AM / 3 months ago

BRIEF-Hangzhou Tianmushan Pharmaceutical Enterprise unit receives GMP certificate

June 30 (Reuters) - Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd :

* Says its unit received goods manufacture practice (GMP) certificate from Anhui Food and Drug Administration

* Certificate issued tablets, granules, pills manufactured by the unit and the valid period is until June 27, 2022

Source text in Chinese: goo.gl/yyru5K

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below